Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Ohio Medical Board Changes Telemedicine Rules

Client Alert
November 16, 2021

Click here to read an article by BMD Healthcare and Hospital Law Member Scott Sandrock from the Fall 2021 Edition of the Stark County Medical Society News.

Scott P. SandrockHealthcare and Hospital Law
Client Alert

Checklist of Legal Considerations for a Med Spa

December 23, 2024Checklist of key legal considerations for a med spa providing a broad overview of certain state and federal legal requirements.Client Alert

Understanding Ohio House Bill 660: A Game-Changer for Student-Athletes

December 13, 2024Ohio House Bill 660 is set to reshape Name, Image, and Likeness (NIL) agreements for student-athletes by allowing direct compensation from universities and providing greater financial opportunities while preserving amateur status. The bill simplifies the regulatory framework, introduces safeguards, and creates challenges and ethical considerations for stakeholders.Client Alert

Effective December 12, 2024: Key Updates to Ohio Medicaid Rules for CPC and CMC Programs

December 12, 2024Ohio Medicaid has amended rules for the Comprehensive Primary Care (CPC) and Comprehensive Maternal Care (CMC) programs, effective December 12, 2024. Key updates include expanded provider eligibility, stricter cultural competency training timelines, new clinical quality metrics, and changes to maternal care requirements.Client Alert

Ohio Medicaid Extends Timely Filing Deadline Until 2025

December 11, 2024The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.Client Alert

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

December 11, 2024Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.
Older posts